Streetbeat News

Products Services

AMC

GME

KOSS

Koss Corp (NASDAQ:KOSS) has experienced a significant stock price surge due to Keith Gill, aka 'Roaring Kitty,' re-emerging on social media. Despite the excitement, Koss's fundamentals are weak, with declining net sales and increased net losses. Technical analysis shows a bullish trend, but caution is advised as meme stock rallies often lead to pullbacks.

Portfolio Pulse from Surbhi Jain

June 03, 2024 | 6:46 pm

BIIB

DAL

Biogen Inc. (NASDAQ:BIIB) shares surged after announcing a partnership with Delta Flight Products, a subsidiary of Delta Air Lines (NYSE:DAL), to enhance air travel accessibility for passengers with reduced mobility. The collaboration aims to develop innovative solutions, including a new airplane seat prototype that allows passengers to remain in their wheelchairs during flights.

Portfolio Pulse from Vaishali Prayag

June 03, 2024 | 6:43 pm

BPTH

CAMP

CNSP

GME

LSCC

MBOT

SAIC

U.S. stocks traded mostly lower with the Dow Jones falling over 300 points. GameStop shares spiked 35% after a Reddit post by Roaring Kitty. Bio-Path Holdings and Microbot Medical saw significant gains due to positive news, while CalAmp Corp shares plummeted 60% following a Chapter 11 bankruptcy filing. Lattice Semiconductor and CNS Pharmaceuticals also experienced notable declines.

Portfolio Pulse from Avi Kapoor

June 03, 2024 | 6:35 pm

NHC

National HealthCare Corporation (NHC) announced its plan to acquire White Oak Senior Living Portfolio in North and South Carolina, which includes a long-term care pharmacy. The transaction is expected to close in Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:34 pm

PBYI

Puma Biotechnology presented a Phase I/Ib study on Alisertib for treating Osimertinib-resistant EGFR-mutated lung cancer at ASCO 2024.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:33 pm

JNJ

Johnson & Johnson announced new Phase 2 data from the PALOMA-2 study showing that subcutaneous amivantamab combined with lazertinib provides a clinically meaningful antitumor response and improved safety profile in patients with EGFR-mutated non-small cell lung cancer. The results were presented at the 2024 ASCO Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:33 pm

MRUS

Merus N.V. (NASDAQ:MRUS) presented a poster at the 2024 ASCO Annual Meeting showcasing the single-agent efficiency of MCLA-129 in METex14 NSCLC.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:31 pm

ARW

AVGO

Arrow Electronics has signed a new distribution agreement with VMWare and Broadcom in Europe, which could enhance its product offerings and market reach.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:21 pm

OCX

Oncocyte's VitaGraft Kidney Diagnostic Test has shown promising Phase 2 results in transplant monitoring, as published in the New England Journal of Medicine.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 6:15 pm

AFMD

Affimed N.V. (NASDAQ: AFMD) shares surged on Monday following the release of promising clinical data from its AFM24-102 study in non-small cell lung cancer (NSCLC). The data showed significant clinical efficacy and a manageable safety profile for the combination of AFM24 and atezolizumab, leading to an 81.4% increase in AFMD's stock price.

Portfolio Pulse from Vandana Singh

June 03, 2024 | 6:13 pm